GMI-1070

DRUG2 trials

Sponsors

GlycoMimetics Incorporated

Conditions

Pain CrisisSickle Cell DiseaseVaso-occlusive Crisis

Phase 1

Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease

CompletedNCT00911495

GlycoMimetics IncorporatedSickle Cell Disease

Start: 2009-05-31End: 2010-09-30Updated: 2020-05-11

Phase 2

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

CompletedNCT01119833

GlycoMimetics IncorporatedPain Crisis, Sickle Cell Disease, Vaso-occlusive Crisis

Start: 2010-05-31End: 2013-12-31Updated: 2020-05-13

Related Papers

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use

Blood2015-03-02204 citations

Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia

PLoS ONE2014-07-0268 citations